331 related articles for article (PubMed ID: 24332433)
1. Emergency contraception with a copper IUD or oral levonorgestrel: an observational study of 1-year pregnancy rates.
Turok DK; Jacobson JC; Dermish AI; Simonsen SE; Gurtcheff S; McFadden M; Murphy PA
Contraception; 2014 Mar; 89(3):222-8. PubMed ID: 24332433
[TBL] [Abstract][Full Text] [Related]
2. Preference for and efficacy of oral levonorgestrel for emergency contraception with concomitant placement of a levonorgestrel IUD: a prospective cohort study.
Turok DK; Sanders JN; Thompson IS; Royer PA; Eggebroten J; Gawron LM
Contraception; 2016 Jun; 93(6):526-32. PubMed ID: 26944863
[TBL] [Abstract][Full Text] [Related]
3. One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraception.
Sanders JN; Turok DK; Royer PA; Thompson IS; Gawron LM; Storck KE
Contraception; 2017 Aug; 96(2):99-105. PubMed ID: 28596121
[TBL] [Abstract][Full Text] [Related]
4. Choice of Emergency Contraceptive and Decision Making Regarding Subsequent Unintended Pregnancy.
Royer PA; Turok DK; Sanders JN; Saltzman HM
J Womens Health (Larchmt); 2016 Oct; 25(10):1038-1043. PubMed ID: 27032057
[TBL] [Abstract][Full Text] [Related]
5. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S;
Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
[TBL] [Abstract][Full Text] [Related]
6. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
7. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
Heinemann K; Reed S; Moehner S; Minh TD
Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
[TBL] [Abstract][Full Text] [Related]
8. Progestin intrauterine devices versus copper intrauterine devices for emergency contraception.
Ramanadhan S; Goldstuck N; Henderson JT; Che Y; Cleland K; Dodge LE; Edelman A
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013744. PubMed ID: 36847591
[TBL] [Abstract][Full Text] [Related]
9. Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception.
Turok DK; Gero A; Simmons RG; Kaiser JE; Stoddard GJ; Sexsmith CD; Gawron LM; Sanders JN
N Engl J Med; 2021 Jan; 384(4):335-344. PubMed ID: 33503342
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of the Copper T380A IUD and oral levonorgestrel for emergency contraception.
Turok DK; Gurtcheff SE; Handley E; Simonsen SE; Sok C; Murphy P
Contraception; 2010 Dec; 82(6):520-5. PubMed ID: 21074014
[TBL] [Abstract][Full Text] [Related]
11. Interventions for emergency contraception.
Shen J; Che Y; Showell E; Chen K; Cheng L
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD001324. PubMed ID: 28766313
[TBL] [Abstract][Full Text] [Related]
12. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE
Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
[TBL] [Abstract][Full Text] [Related]
13. Interventions for emergency contraception.
Shen J; Che Y; Showell E; Chen K; Cheng L
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD001324. PubMed ID: 30661244
[TBL] [Abstract][Full Text] [Related]
14. Safety of levonorgestrel 52 mg intrauterine system compared to copper intrauterine device: a population-based cohort study.
Bosco-Lévy P; Gouverneur A; Langlade C; Miremont G; Pariente A
Contraception; 2019 Jun; 99(6):345-349. PubMed ID: 30871933
[TBL] [Abstract][Full Text] [Related]
15. The safety of intrauterine devices among young women: a systematic review.
Jatlaoui TC; Riley HEM; Curtis KM
Contraception; 2017 Jan; 95(1):17-39. PubMed ID: 27771475
[TBL] [Abstract][Full Text] [Related]
16. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium
Lancet; 2019 Jul; 394(10195):303-313. PubMed ID: 31204114
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A.
Rowe P; Farley T; Peregoudov A; Piaggio G; Boccard S; Landoulsi S; Meirik O;
Contraception; 2016 Jun; 93(6):498-506. PubMed ID: 26916172
[TBL] [Abstract][Full Text] [Related]
18. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
Suvisaari J; Lähteenmäki P
Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872
[TBL] [Abstract][Full Text] [Related]
19. Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle.
Turok DK; Godfrey EM; Wojdyla D; Dermish A; Torres L; Wu SC
Hum Reprod; 2013 Oct; 28(10):2672-6. PubMed ID: 23945595
[TBL] [Abstract][Full Text] [Related]
20. Use of ulipristal acetate and levonorgestrel for emergency contraception: a follow-up study.
Baird AS; Trussell J; Webb A
J Fam Plann Reprod Health Care; 2015 Apr; 41(2):116-21. PubMed ID: 24869461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
